Artiva Biotherapeutics, Inc. ARTV Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $19.31M+13.6% | $16.99M-3.6% | $17.63M-1.3% | $17.86M+4.7% | $17.05M+28.0% | ||
| $5.12M+3.6% | $4.94M-6.2% | $5.26M+6.4% | $4.95M-3.3% | $5.12M+3.4% | ||
| $24.43M+11.4% | $21.93M-4.2% | $22.9M+0.4% | $22.81M+2.9% | $22.17M+21.4% | ||
| -$24.43M-11.4% | -$21.93M+4.2% | -$22.9M-0.4% | -$22.81M-2.9% | -$22.17M-21.4% | ||
| $914K-21.2% | $1.16M-15.3% | $1.37M-12.0% | $1.56M-16.3% | $1.86M-14.4% | ||
| -$23.52M-13.2% | -$20.77M+3.5% | -$21.53M-1.3% | -$21.25M-4.6% | -$20.31M-26.2% | ||
| -$0.95-13.1% | -$0.84+4.5% | -$0.88-1.1% | -$0.87-4.8% | -$0.83— | ||
| -$23.76M-11.7% | -$21.27M+4.4% | -$22.24M-0.3% | -$22.17M-2.9% | -$21.54M-22.0% | ||
| -$24.43M-11.4% | -$21.93M+4.2% | -$22.9M-0.4% | -$22.81M-2.9% | -$22.17M-21.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Artiva Biotherapeutics, Inc. profitable?
- Artiva Biotherapeutics, Inc. is not currently profitable: it reported a net loss of $87.1M over the trailing twelve months, a -79.3% net margin.
- What is Artiva Biotherapeutics, Inc.'s earnings per share?
- Artiva Biotherapeutics, Inc.'s diluted EPS over the trailing twelve months is $-3.54.
- Where does Artiva Biotherapeutics, Inc.'s income statement data come from?
- Every line is extracted from Artiva Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.